Company page
Hanall Biopharma Co., Ltd.
Hanall Biopharma Co., Ltd. is a public company based in Korea, trading under the ticker 009420. The company has a market capitalization of approximately $2.11 billion. Hanall Biopharma focuses on developing innovative biopharmaceuticals to address unmet medical needs.
- Ticker
- 009420
- Market cap
- $2.11B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major